Bio Financial Statements From 2010 to 2024
| BIOWKS Stock | SEK 0.88 0.01 1.12% |
Check Bio Works financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Works' main balance sheet or income statement drivers, such as , as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio Works Valuation or Volatility modules.
Bio |
Bio Works Technologies AB Company Operating Margin Analysis
Bio Works' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bio Works Operating Margin | (1.27) % |
Most of Bio Works' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Works Technologies AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Bio Works Technologies AB has an Operating Margin of -1.2713%. This is 96.38% lower than that of the Healthcare sector and 98.87% lower than that of the Biotechnology industry. The operating margin for all Sweden stocks is 76.93% lower than that of the firm.
Bio Works Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio Works's current stock value. Our valuation model uses many indicators to compare Bio Works value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Works competition to find correlations between indicators driving Bio Works's intrinsic value. More Info.Bio Works Technologies AB is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio Works by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio Works' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bio Works Financial Statements
Bio Works stakeholders use historical fundamental indicators, such as Bio Works' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Works investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bio Works' assets and liabilities are reflected in the revenues and expenses on Bio Works' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bio Works Technologies AB. Please read more on our technical analysis and fundamental analysis pages.
Bio-Works Technologies AB researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. Bio-Works Technologies AB founded in 2006 and is based in Uppsala, Sweden. Bio Works is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.